Precision percutaneous coronary intervention
Precision-based percutaneous coronary intervention (PCI) integrates contemporary strategies across the pre-, intra-, and post-procedural phases to improve outcomes and minimize complications. Emerging evidence underscores the value of these strategies in reducing adverse events and improving procedural efficiency. While artificial intelligence and pharmacogenomics hold long-term promise for enhancing personalization, their clinical utility in PCI remains in the early stages of development.
Authors
- Tania Ahuja (ORCID: https://orcid.org/0000-0003-1833-4124)
- Affan Rizwan (ORCID: https://orcid.org/0009-0009-7272-0959)
- Riyan Siddiqui
- Muzamil Khawaja
- Mahboob Alam (ORCID: https://orcid.org/0000-0002-5188-1130)
- Larisa H. Cavallari (ORCID: https://orcid.org/0000-0002-7184-5292)
- Hafeez Ul Hassan Virk (ORCID: https://orcid.org/0000-0002-9835-942X)
- Umair Khalid
- Tanawat Attachaipanich (ORCID: https://orcid.org/0000-0002-1514-4061)
- Uzair Munaf
- Terrance M. Wilson
- S K Sharma
- Nafhat Shaikh
- Lloyd W Klein
- Gary S. Mintz
- Michael G. Nanna
- Chayakrit Krittanawong
Institutions
- Michael E. DeBakey VA Medical Center (US)
- Liaquat University of Medical & Health Sciences (PK)
- Emory University (US)
- University of California, San Francisco (US)
- Baylor College of Medicine (US)
- University Hospitals of Cleveland (US)
- University of Mississippi Medical Center (US)
- Yale University (US)
- University of Florida (US)
- NYU Langone Health (US)
- Mount Sinai Hospital (US)
- Cardiovascular Research Foundation (US)
- New York University (US)
- University of Missouri–Kansas City (US)
- Florida College (US)
Publication Details
- Journal
- npj Cardiovascular Health
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1038/s44325-026-00111-y
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00